11
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Malignant ureteral obstruction: experience and comparative analysis of metallic versus ordinary polymer ureteral stents

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          To study the outcome and experience of using metallic stents in treating patients with malignant ureteral obstruction (MUO).

          Methods

          Seventy-six patients with MUO were assigned to the metallic stent group (MSG) or the ordinary polymer stent group (OPSG) according to the different materials. The success rate of the operation, duration of operation, patency rate serum creatinine values ,postoperative complications and QOL scores were compared between the two groups.

          Results

          In the OPSG and MSG, the success rates of the operation were 95.5% and 96.9%, respectively, and the durations of the operation were 20.6 ± 2.2 min and 50.9 ± 10.3 min ( P < 0.01), respectively. There was no significant difference between the groups in serum creatinine values at 3 days after the operation ( P > 0.05); however, the creatinine values at 3 days after the operation decreased significantly compared with those before the operation ( P < 0.01). In the OPSG, there was no significant difference in creatinine values between 3 days and 6 months after operation, while the creatinine values 1 year after operation were increased significantly compared to those at 3 days after the operation ( P < 0.05). In the MSG, there was no significant difference among creatinine values at different intervals ( P > 0.05). The total rate of post-procedural complication was lower in the MSG than that in the OPSG( P < 0.05). There was no significant difference in the QOL score between the two groups before the operation ( P > 0.05); however, the QOL scores at 6 months and 1 year after the operation were higher in the MSG than that in the OPSG( P < 0.05). In the MSG, there was no significant difference in the QOL score between preoperation and 6 months after surgery. Similarly, there was also no difference in the QOL score between 6 months after surgery and 1 year after surgery( P > 0.05). On the contrary, the differences of QOL score in the OPSG group were much significant between disparate time intervals ( P < 0.05).

          Conclusions

          For patients with MUO who require long-term retention of the stent, metallic stents with longer indwelling time are superior to ordinary polymeric stents.

          Related collections

          Most cited references25

          • Record: found
          • Abstract: found
          • Article: not found

          Outcomes of metallic stents for malignant ureteral obstruction.

          Malignant ureteral obstruction often necessitates chronic urinary diversion and is associated with high rates of failure with traditional ureteral stents. We evaluated the outcomes of a metallic stent placed for malignant ureteral obstruction and determined the impact of risk factors previously associated with increased failure rates of traditional stents. Patients undergoing placement of the metallic Resonance® stent for malignant ureteral obstruction at an academic referral center were identified retrospectively. Stent failure was defined as unplanned stent exchange or nephrostomy tube placement for signs or symptoms of recurrent ureteral obstruction (recurrent hydroureteronephrosis or increasing creatinine). Predictors of time to stent failure were assessed using Cox regression. A total of 37 stents were placed in 25 patients with malignant ureteral obstruction. Of these stents 12 (35%) were identified to fail. Progressive hydroureteronephrosis and increasing creatinine were the most common signs of stent failure. Three failed stents had migrated distally and no stents required removal for recurrent infection. Patients with evidence of prostate cancer invading the bladder at stent placement were found to have a significantly increased risk of failure (HR 6.50, 95% CI 1.45-29.20, p = 0.015). Notably symptomatic subcapsular hematomas were identified in 3 patients after metallic stent placement. Failure rates with a metallic stent are similar to those historically observed with traditional polyurethane based stents in malignant ureteral obstruction. The invasion of prostate cancer in the bladder significantly increases the risk of failure. Patients should be counseled and observed for subcapsular hematoma formation with this device. Copyright © 2012 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Metallic ureteral stents: a cost-effective method of managing benign upper tract obstruction.

            The management of patients with upper urinary tract obstruction who are not candidates for definitive reconstruction often presents a challenge. We report our initial experience with the Resonance (Cook Urological, Spencer, IN) metallic ureteral stent for the management of benign ureteral obstruction and present a comparative cost analysis of metallic to standard polymer stent use. Data were retrospectively gathered on all patients undergoing metallic ureteral stent placement for benign causes from July 2007 to February 2009. Baseline demographics, previous method of drainage, pre- and postoperative creatinine levels, procedural complications, stent-related side effects, and metallic stent dwell time were recorded. The cost of stent maintenance for polymer and metallic stents for a 12-month interval was calculated for each patient. Fifteen stents were placed in 13 patients to manage obstruction due to a variety of benign etiologies. Metallic stents provided adequate drainage in 12/13 patients, but were discontinued prematurely in 3 patients (2 for voiding symptoms, 1 for hematuria). Eight patients had their metallic stents changed after a mean time of 11.6 months, with no encrustation. The yearly cost associated with polymer and metallic stent use was $23,999 and $11,183, respectively. This amounted to a $10,394 annual cost reduction (43%) for each patient. Metallic ureteral stents provide effective upper tract drainage for the majority of patients with benign upper tract obstruction, with significant cost benefit, largely because of the shorter exchange interval.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Initial clinical experience with full-length metal ureteral stents for obstructive ureteral stenosis.

              Long-term ureteral stenting is used to ensure urinary drainage if a reconstructive approach or a release of an extrinsic obstruction is not possible. In this contribution, a long-term experience with a new full-length, metal indwelling stent is presented. Fourteen patients with ureteral obstruction received full metal indwelling stents in 18 collecting systems (benign disease in 5 and malignant disease in 13). Stent placement was performed cystoscopically under fluoroscopic guidance. Follow-up was done every 3 months with ultrasonographic examination, creatinine levels, and a visual analog pain score. Eight stents were removed, whereas eight are still in situ. One patient without stent-related problems died because of progressive rectal cancer 9 months after bilateral stent insertion. Mean stent duration (8 stents still in situ) is 8.6 months, whereas mean stent duration for benign and malignant disease is 11.8 (median 13) and 7.3 (median 6) months, respectively (p<0.05). All removed stents were extracted endoscopically without any problems and had no incrustation except two. Neither migration nor mechanical damage was observed. This novel stent is easy to insert and remove. It is an option for patients in which a surgical reconstruction of the obstructed ureter is not possible. Stents have been developed further and are now available in various lengths. This might result in a reduction of problems associated with inadequate stent length and should increase patient comfort and stent durability.
                Bookmark

                Author and article information

                Contributors
                +86-022-88329692 , chenyue831106@163.com
                +86+13395646198 , Liuchengyi2019@163.com
                +86+13920695369 , 1191960781@qq.com
                +86+13966248910 , xupc2016@126.com
                +86+13865758643 , chengdegang.908@163.com
                +86+13865796960 , fanxinhuan2001@yahoo.com.cn
                +86+13637254446 , majici@sina.com
                +86+15868413863 , 420993645@qq.com
                Journal
                World J Surg Oncol
                World J Surg Oncol
                World Journal of Surgical Oncology
                BioMed Central (London )
                1477-7819
                30 April 2019
                30 April 2019
                2019
                : 17
                : 74
                Affiliations
                [1 ]ISNI 0000 0004 1798 6160, GRID grid.412648.d, Department of Urology, , The Second Hospital of Tianjin Medical University, ; No.23, Pingjiang Road, Hexi Disctrict, Tianjin, 300211 China
                [2 ]ISNI 0000 0000 9490 772X, GRID grid.186775.a, Department of Urology, , Lu’an Affiliated Hospital of Anhui Medical University, ; Lu’an, 237000 Anhui China
                [3 ]ISNI 0000 0004 1808 0985, GRID grid.417397.f, Institute of Urology, , Zhejiang Cancer Hospital, ; Hangzhou, 310000 ZheJiang China
                Author information
                http://orcid.org/0000-0002-7632-8796
                Article
                1608
                10.1186/s12957-019-1608-6
                6492337
                31039812
                be51af2c-e7b9-4b11-b254-8d237abd1399
                © The Author(s). 2019

                Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License ( http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

                History
                : 24 January 2019
                : 26 March 2019
                Categories
                Research
                Custom metadata
                © The Author(s) 2019

                Surgery
                metallic stent,contrast study,malignant,ureteral obstruction
                Surgery
                metallic stent, contrast study, malignant, ureteral obstruction

                Comments

                Comment on this article